SPDR® S&P Biotech ETFXBI:PCQ:USD

156.08
0.51 / 0.33%
114.12 - 172.52+1.36
Close in USDToday's change52-week range3-yr sharpe ratio
Data delayed at least 15 minutes, as of Oct 17 2014 21:00 BST.

Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.

Profile

Fund typeOpen Ended Investment Company
Investment style (stocks)
Market Cap: Small
Investment Style: Growth
Morningstar categoryHealth
Launch date31/01/2006
Price currencyUSD
DomicileUnited States
SymbolXBI
Manager & start date
John Tucker
31/01/2006
Michael Feehily
31/10/2011

Investment

Total net assets
1.19bn USDAs of Sep 30 2014
Market cap1.23bn USD
Shares outstanding7.90m
Average volume (10-day)774.83k
Net expense ratio0.35%
Last dividend0.5628 USD
Div yield0.99%
Div ex-date09/19/2014
Div pay-date09/29/2014
Available for saleMexico, United States

Diversification

Asset type

US stock
98.72%
Non-US stock
2.55%
Cash
1.40%
Non-US bond
0.00%
US bond
0.00%
Other
-2.67%

Top 5 sectors

Healthcare
101.27%

Top 5 Regions

United States
98.72%
Eurozone
2.55%

Sector and region weightings are calculated using only long position holdings of the portfolio.

Sector & regional holdings

Top 5 holdings

Company1 year
change
Portfolio
weight
Long
allocation
Agios Pharmaceuticals Inc
AGIO:NSQ
+126.30%1.85%
PTC Therapeutics Inc
PTCT:NSQ
+90.19%1.79%
AMAG Pharmaceuticals Inc
AMAG:NSQ
+48.14%1.64%
Vertex Pharmaceuticals Inc
VRTX:NSQ
+33.16%1.61%
Merrimack Pharmaceuticals Inc
MACK:NMQ
+137.75%1.61%
Data delayed at least 15 minutes, as of Sep 30 2014.Top 10 holdings
Intra-day ETF pricing data provided by
© Thomson Reuters Click for restrictions.

The performance data shown in tables and graphs on this page is calculated in USD of the fund / index / average (as applicable), on a Bid To Bid / Nav to Nav basis, with gross dividends re-invested on ex-dividend date. Past performance is not necessarily a guide to future performance; unit prices may fall as well as rise.

All managed funds data located on FT.com is subject to the FT Terms & Conditions . All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

All data shown on this page, unless noted otherwise is Data Source and Copyright: Morningstar, Inc. 2014
All Rights reserved

© 2014 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.

The Morningstar Equity Style Box is a unique graphical tool showing a fund’s true investment style and market capitalisation.

The Morningstar Fixed Income Style Box is a unique graphical tool showing a fund's true credit quality and duration.

Pricing for ETFs is the latest price and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.